Justin Bryans

Executive Director of Drug Discovery at LifeArc

Justin BryansJustin Bryans is the Executive Director of Drug Discovery at LifeArc. He has worked for over 20 years as a medicinal chemist in a number of Biotechnology and Pharma companies, including Xenova, Parke-Davis and Pfizer, developing clinical candidates for a wide range of diseases and more than 50 patent applications in the process. He joined MRCT in 2005 where he currently leads the drug discovery operation.

MRCT has already helped develop two marketed drugs, TysabriTM and ActemraTM and has delivered other assets of which at least eight are still in active clinical development. Justin is also an Honorary Professor at Queen Mary University of London (QMUL) and undertakes teaching on drug discovery at QMUL, University College London and the Wellcome Trust.

Related organisations

Related people